XML 18 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Assets    
Cash and cash equivalents $ 35,387 $ 28,899
Restricted cash 1,506 1,612
Investments 17,434 22,664
Receivables from collaborations 5,968 6,243
Inventory 2,232 1,612
Prepaid expenses and other current assets 2,007 2,674
Deferred collaboration expense 98 90
Total current assets 64,632 63,794
Investments 14,371 47,683
Property and equipment, net 10,095 5,149
Deferred collaboration expense 214 265
Other assets 2,190 5,468
Total assets 91,502 122,359
Liabilities and Stockholders’ Equity    
Accounts payable 2,760 9,307
Accrued expenses 10,782 16,237
Interest payable 7,563 6,746
Deferred collaboration revenue 2,282 2,163
Non-recourse notes payable 28,133 27,804
Total current liabilities 51,520 62,257
Deferred collaboration revenue 8,480 9,674
Deferred rent 265 329
Foreign currency derivative 1,904
Lease financing obligation 2,675 2,375
Senior credit facility 22,665
Stockholders’ equity:    
Preferred stock, $0.001 par value; shares authorized — 5,000; no shares issued and outstanding
Common stock, $0.01 par value: shares authorized — 200,000; shares issued and outstanding — 73,758 in 2016 and 73,355 in 2015 738 734
Additional paid-in capital 564,791 558,113
Accumulated other comprehensive income (loss) 22 (206)
Accumulated deficit (561,558) (510,917)
Total stockholders’ equity 3,993 47,724
Total liabilities and stockholders’ equity $ 91,502 $ 122,359